S100B and major depressive disorder: Histopathological analysis of autopsy brain samples from MDD patients revealed a considerable reduction in glial cell density, as evidenced by a decrease in the number of cells expressing S100B [49], as well as a momentous reduction in GFAP expression in several brain regions, including the hippocampus [50].